A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Study sponsor: Kodiak Sciences Inc · KOD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-08-31Estimated
Enrollment · participants910Estimated
Source updated2026-11-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.